ScholarIQanswers from OpenAlex

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

PaperCitations, authors & open-access status

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer have?

ScholarIQcitation count

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer has 5,744 citations in the OpenAlex counts ScholarIQ stores.

When was Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer published?

ScholarIQyear

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer has 2004 year in the ScholarIQ index.

What is the open-access status of Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer?

ScholarIQoa status

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer has closed oa status in the ScholarIQ index.

What is the DOI of Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer?

ScholarIQdoi

The DOI for Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer is on the source record.

What is the PMID of Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer?

ScholarIQpmid

The PMID for Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer is on the source record.

What is the OpenAlex record for Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer?

ScholarIQopenalex

The OpenAlex for Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial